U.S. prosecutors are looking into a claim that GSK (GSK) scientist, who formerly worked at Pfizer (PFE), told colleagues that Pfizer delayed announcing the success of its Covid vaccine in 2020 until after that year’s election, Josh Dawsey, Gregory Zuckerman, and Jared Hopkins of Wall Street Journal report. The scientist disputes that account of what he told colleagues, but prosecutors are taking a closer look at what GSK shared with them, according to the Journal. President Trump for years has claimed that Pfizer sat on the positive results of clinical trials, the Journal notes. The U.S. attorney’s office in Manhattan has interviewed at least two people in connection with the allegation, a person familiar with the matter told the paper.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- U.S. to end funding for child vaccines in developing countries, NY Times reports
- Large pharma M&A deals stalling amid volatile policies, Reuters reports
- Notable open interest changes for March 26th
- China Highlights Business Opportunities to America’s Apple (AAPL) and Pfizer
- China Woos Foreign CEOs with Call to Resist Protectionism as Trump Weighs Tariffs